相关实验视频
Updated: Sep 8, 2025

09:25
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
Published on: June 28, 2013
27.1K
形式遵循功能:胰腺癌进展的新范式
bioRxiv : the preprint server for biology
|August 20, 2025
概括
胰腺癌通过采用特定的几何形状来侵入附近的组织. 对H&E图像的AI分析显示,这些瘤结构与具有侵略性的分子特征和患者结果相关.
科学领域:
- 在瘤学瘤学.
- 计算病理学计算病理学
- 癌症生物学 癌症生物学
背景情况:
- 胰腺管腺癌 (PDAC) 以其侵略性的局部入侵和血管透而闻名,但潜在的机制仍然不清楚.
- 了解分子变化和PDAC的物理行为之间的联系对于改善患者的治疗结果至关重要.
研究的目的:
- 研究PDAC瘤结构的空间和几何特性及其与侵入性和分子亚型的相关性.
- 开发和验证人工智能辅助的计算工具,用于分析瘤形态和预测临床行为.
主要方法:
- 从H&E图像开发一个大规模的,人工智能辅助的PDAC地图,注释超过144,000个结构.
- 创建了SHAPE计算工具,用于几何化癌症进展和分析形态.
- 将形态数据与整个基因组,RNA测序和PDAC患者的空间转录组数据集成.
主要成果:
- 侵入PDAC结构表现出古怪的形态和局部角连贯性,紧密跟踪血管和神经.
- 奇特的结构与增加的副本数变化,染色体17p上的异构性丧失以及准介质/基底类分子亚型相关.
- 在异常结构中通过空间转录学证实了像EMT,血管生成和凝血通路这样的侵入性程序的升级.
结论:
- PDAC表现出独特的瘤结构,其特点是特定的几何和空间特性,与其侵略性行为有关.
- 人工智能驱动的形态分析提供了一个强大的,可解释的方法来评估PDAC的攻击性,预测治疗反应,并指导临床管理.
相关概念视频
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K

